Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Legislation
Energy & Commerce Health Subcommittee releases several discussion drafts at hearing on 340B drug discount program reform as the debate seems poised to move into the next phase.
A survey of EU member states has shown wide variations in the way that they deal with shortages and discontinuation of medicines.
The BioIndustry Association is concerned about the lack of clarity on future UK-EU drug regulation after EU heads of state failed to make any tangible progress on Brexit at their much heralded end-of-June summit.
Legislation that would introduce the proposed mandatory scheme for reporting medicines shortages has come before the Australian parliament. Among other things it specifies which shortages would have a "critical impact" on patient health.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.